These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28978114)

  • 1. MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.
    Liu L; Cai X; Liu E; Tian X; Tian C
    Oncotarget; 2017 Sep; 8(40):68263-68269. PubMed ID: 28978114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
    Wang X; Lu J; Cao J; Ma B; Gao C; Qi F
    Onco Targets Ther; 2018; 11():7919-7934. PubMed ID: 30519035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
    Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L
    Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.
    Zhang X; Yu B; Zhang F; Guo Z; Li L
    Chin Med Sci J; 2017 Apr; 32(1):34-3. PubMed ID: 28399983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.
    Chen Z; Ma Y; Pan Y; Zuo S; Zhu H; Yu C; Zhu C; Sun C
    Onco Targets Ther; 2019; 12():10717-10726. PubMed ID: 31827329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circRHOBTB3 is downregulated in hepatocellular carcinoma and suppresses cell proliferation by inhibiting miR-18a maturation.
    Hu G; Zhai S; Yu S; Huang Z; Gao R
    Infect Agent Cancer; 2021 Jun; 16(1):48. PubMed ID: 34187598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
    Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
    Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.
    Lv H; Zhang Z; Wang Y; Li C; Gong W; Wang X
    Oncol Res; 2016; 23(6):283-90. PubMed ID: 27131314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.
    Cui M; Qu F; Wang L; Cheng D; Liu X
    Technol Cancer Res Treat; 2021; 20():15330338211043976. PubMed ID: 34738854
    [No Abstract]   [Full Text] [Related]  

  • 11. Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA.
    Luo YY; Tao KG; Lu YT; Li BB; Wu KM; Ding CH; Yan FZ; Liu Y; Lin Y; Zhang X; Zeng X
    Front Pharmacol; 2022; 13():819735. PubMed ID: 35264957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.
    Li CL; Yeh KH; Liu WH; Chen CL; Chen DS; Chen PJ; Yeh SH
    Int J Cancer; 2015 Feb; 136(4):761-70. PubMed ID: 24975878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2.
    Lu C; Peng K; Guo H; Ren X; Hu S; Cai Y; Han Y; Ma L; Xu P
    Oncol Lett; 2018 Sep; 16(3):3150-3156. PubMed ID: 30127908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.
    Quan B; Liu W; Yao F; Li M; Tang B; Li J; Ren Z; Yin X
    Am J Cancer Res; 2023; 13(11):5590-5609. PubMed ID: 38058825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma.
    Hujie G; Zhou SH; Zhang H; Qu J; Xiong XW; Hujie O; Liao CG; Yang SE
    Cancer Cell Int; 2018; 18():10. PubMed ID: 29375271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR-18a-5p/NEDD9 axis.
    Zheng Y; Nie P; Xu S
    J Cell Biochem; 2020 Jun; 121(5-6):3135-3144. PubMed ID: 31916278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells.
    Liu Z; Wang J; Mao Y; Zou B; Fan X
    Oncol Lett; 2016 Jan; 11(1):433-438. PubMed ID: 26870229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer.
    Zhang Z; Li JZ; Wei ZW; Li F; Li HM; Xiao Y; Qin YQ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3586-3591. PubMed ID: 32329833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.